Page 2 - Cidara Therapeutics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Needham & Company LLC Reaffirms Buy Rating for Cidara Therapeutics (NASDAQ:CDTX)

Needham & Company LLC restated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report report published on Thursday, Benzinga reports. Needham & Company LLC currently has a $25.00 price target on the biotechnology company’s stock. CDTX has been the topic of several other reports. WBB Securities reaffirmed a […]

United statesCantor fitzgeraldNeedham companyCidara therapeutics incRaymond james financial services advisors incCidara therapeuticsFree reportTherapeutics stock downGet free reportJames financial services advisorsFire capitalCidara therapeutics daily

Contrasting Humacyte (NASDAQ:HUMA) and Cidara Therapeutics (NASDAQ:CDTX)

Contrasting Humacyte (NASDAQ:HUMA) and Cidara Therapeutics (NASDAQ:CDTX)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesSan diegoCidara therapeutics incTherapeutics incHumacyte incCidara therapeuticsGet free reportGiven cidara therapeuticCidara therapeutics daily

Cidara Therapeutics, Inc (NASDAQ:CDTX) Given Average Rating of Buy by Analysts

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average rating of “Buy” from the four brokerages that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year […]

United statesNeedham companyFlagship harbor advisorsCantor fitzgeraldCidara therapeutics company profileRaymond james financial services advisors incCidara therapeutics incCidara therapeuticsGet free reportMarketbeat ratingsJames financial services advisorsHarbor advisorsPale fire capitalGet freeCidara therapeutics dailyNasdaq cdtx

Cidara Therapeutics (NASDAQ:CDTX) Shares Gap Up on Analyst Upgrade

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […]

United statesRaymond james financial services advisors incNeedham companyCidara therapeutics company profileFlagship harbor advisorsCantor fitzgeraldCidara therapeutics incCidara therapeuticsGet free reportHarbor advisorsJames financial services advisorsPale fire capitalCidara therapeutics dailyNasdaq cdtx

WBB Securities Reaffirms Strong-Buy Rating for Cidara Therapeutics (NASDAQ:CDTX)

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “strong-buy” rating reiterated by stock analysts at WBB Securities in a note issued to investors on Thursday, Benzinga reports. They currently have a $40.00 price target on the biotechnology company’s stock. WBB Securities’ price target would indicate a potential upside of 207.69% from the stock’s […]

United statesCidara therapeutics incNeedham companyRaymond james financial services advisors incFlagship harbor advisorsCantor fitzgeraldCidara therapeuticsGet free reportJames financial services advisorsFire capitalCidara therapeutics dailyNasdaq cdtxReiterated ratingWbb securities